 BERKELEY, Calif. and MAINZ, Germany, Sept. 01, 2022 GLOBE NEWSWIRE -- Mainz Biomed N.V. NASDAQ:MYNZ Mainz Biomed or the Company, a molecular genetics diagnostic company specializing in the early detection of cancer, announced today that Bill Caragol, Chief Financial Officer, will present at the H.C. Wainwright Annual Global Investment Conference taking place from September 12-14, 2022. 